Utilization of breast cancer screening with magnetic resonance imaging in community practice

被引:27
|
作者
Hill, Deirdre A. [1 ,2 ]
Haas, Jennifer S. [3 ]
Wellman, Robert [4 ]
Hubbard, Rebecca A. [5 ]
Lee, Christoph I. [6 ,7 ]
Alford-Teaster, Jennifer [8 ,9 ]
Wernli, Karen J. [4 ]
Henderson, Louise M. [10 ]
Stout, Natasha K. [11 ,12 ]
Tosteson, Anna N. A. [9 ,13 ]
Kerlikowske, Karla [14 ,15 ]
Onega, Tracy [8 ,9 ,13 ]
机构
[1] Univ New Mexico, Sch Med, Dept Internal Med, 1 Univ New Mexico,MSC 10-5550 87131-0001, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Sch Med, Ctr Comprehens Canc, Albuquerque, NM 87131 USA
[3] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA
[4] Grp Hlth Res Inst, Seattle, WA USA
[5] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA
[6] Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98195 USA
[7] Univ Washington, Dept Hlth Serv, Sch Publ Hlth, Seattle, WA 98195 USA
[8] Geisel Sch Med Dartmouth, Dept Biomed Data Sci & Epidemiol, Lebanon, NH USA
[9] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA
[10] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA
[11] Harvard Med Sch, Dept Populat Med, Boston, MA USA
[12] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
[13] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Management, Dept Med, Lebanon, NH USA
[14] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[15] Univ Calif San Francisco, Dept Epidemiol Biostat, San Francisco, CA 94143 USA
关键词
breast neoplasms; magnetic resonance imaging; guideline adherence; early detection of cancer; risk factors; CARCINOMA IN-SITU; HIGH FAMILIAL RISK; COST-EFFECTIVENESS; MUTATION CARRIERS; BRCA2; MUTATION; WOMEN; MAMMOGRAPHY; SURVEILLANCE; MRI; ULTRASOUND;
D O I
10.1007/s11606-017-4224-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND: Breast cancer screening with magnetic resonance imaging (MRI) may be a useful adjunct to screening mammography in high-risk women, but MRI uptake may be increasing rapidly among low-and average-risk women for whom benefits are unestablished. Comparatively little is known about use of screening MRI in community practice. OBJECTIVE: To assess relative utilization of MRI among women who do and do not meet professional society guidelines for supplemental screening, and describe utilization according to breast cancer risk indications. DESIGN: Prospective cohort study conducted between 2007 and 2014. PARTICIPANTS: In five regional imaging registries participating in the Breast Cancer Surveillance Consortium (BCSC), 348,955 women received a screening mammogram, of whom 1499 underwent screening MRI. MAIN MEASURES: Lifetime breast cancer risk (< 20% or >= 20%) estimated by family history of two or more first-degree relatives, and Gail model risk estimates. Breast Imaging Reporting and Data System breast density and benign breast diseases also were assessed. Relative risks (RR) for undergoing screening MRI were estimated using Poisson regression. KEY RESULTS: Among women with < 20% lifetime risk, which does not meet professional guidelines for supplementary MRI screening, and no first-degree breast cancer family history, screening MRI utilization was elevated among those with extremely dense breasts [RR 2.2; 95% confidence interval (CI) 1.7-2.8] relative to those with scattered fibroglandular densities and among women with atypia (RR 7.4; 95% CI 3.9-14.3.) or lobular carcinoma in situ (RR 33.1; 95% CI 18.0-60.9) relative to women with non-proliferative disease. Approximately 82.9% (95% CI 80.8%-84.7%) of screening MRIs occurred among women who did not meet professional guidelines and 35.5% (95% CI 33.1-37.9%) among women considered at low-to-average breast cancer risk. CONCLUSION: Utilization of screening MRI in community settings is not consistent with current professional guidelines and the goal of delivery of high-value care.
引用
收藏
页码:275 / 283
页数:9
相关论文
共 50 条
  • [22] Magnetic resonance imaging for screening of women at high risk for hereditary breast cancer
    Mokbel, K
    Elkak, AE
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (21) : 4184 - 4184
  • [23] Breast Cancer Screening Using Mammography, Digital Breast Tomosynthesis, and Magnetic Resonance Imaging by Breast Density
    Stout, Natasha K.
    Miglioretti, Diana L.
    Su, Yu-Ru
    Lee, Christoph I.
    Abraham, Linn
    Alagoz, Oguzhan
    de Koning, Harry J.
    Hampton, John M.
    Henderson, Louise
    Lowry, Kathryn P.
    Mandelblatt, Jeanne S.
    Onega, Tracy
    Schechter, Clyde B.
    Sprague, Brian L.
    Stein, Sarah
    Trentham-Dietz, Amy
    van Ravesteyn, Nicolien T.
    Wernli, Karen J.
    Kerlikowske, Karla
    Tosteson, Anna N. A.
    JAMA INTERNAL MEDICINE, 2024, 184 (10) : 1222 - 1231
  • [24] How I report breast magnetic resonance imaging studies for breast cancer staging and screening
    Vinnicombe, Sarah
    CANCER IMAGING, 2016, 16
  • [25] Screening breast magnetic resonance imaging (MRI) in early-stage breast cancer survivors
    Dowton, A. A.
    Meyer, M. E.
    Ruddy, K. J.
    Yeh, E. D.
    Partridge, A. H.
    CANCER RESEARCH, 2012, 72
  • [26] Multireader Study on the Diagnostic Accuracy of Ultrafast Breast Magnetic Resonance Imaging for Breast Cancer Screening
    van Zelst, Jan C. M.
    Vreemann, Suzan
    Witt, Hans-Joerg
    Gubern-Merida, Albert
    Dorrius, Monique D.
    Duvivier, Katya
    Lardenoije-Broker, Susanne
    Lobbes, Marc B. I.
    Loo, Claudette
    Veldhuis, Wouter
    Veltman, Jeroen
    Drieling, Daniel
    Karssemeijer, Nico
    Mann, Ritse M.
    INVESTIGATIVE RADIOLOGY, 2018, 53 (10) : 579 - 586
  • [27] How I report breast magnetic resonance imaging studies for breast cancer staging and screening
    Sarah Vinnicombe
    Cancer Imaging, 16
  • [28] Breast imaging in the young: the role of magnetic resonance imaging in breast cancer screening, diagnosis and follow-up
    Salem, Dorria Saleh
    Kamal, Rasha Mohamed
    Mansour, Sahar Mahmoud
    Salah, Lamiaa Adel
    Wessam, Rasha
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S9 - S18
  • [29] Magnetic Resonance Imaging in Prostate Cancer Screening
    Fazekas, Tamas
    Shim, Sung Ryul
    Basile, Giuseppe
    Baboudjian, Michael
    Koi, Tamas
    Przydacz, Mikolaj
    Abufaraj, Mohammad
    Ploussard, Guillaume
    Kasivisvanathan, Veeru
    Rivas, Juan Gomez
    Gandaglia, Giorgio
    Szarvas, Tibor
    Schoots, Ivo
    van den Bergh, Roderick
    Leapman, Michael
    Nyirady, Peter
    Shariat, Shahrokh
    Rajwa, Pawel
    JAMA ONCOLOGY, 2024, 10 (06) : 745 - 754
  • [30] Screening Breast Magnetic Resonance Imaging: What are the costs?
    Sun, Susie
    Schaefer, Eric
    Hollenbeak, Christopher
    Leung, Anna
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : 127 - 128